Evidence map›Paper›PMID 18469256›Full record

ArticleThe American journal of clinical nutrition2008

Identification and quantitation of cobalamin and cobalamin analogues in human feces.

Robert H Allen, Sally P Stabler

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of clinical nutrition, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 168 citations in OpenAlex.

  1. High dietary BGut microbes · 2026
    Article
  2. Review
  3. Associations between Biomarkers of Vitamin BThe Journal of nutrition · 2026
    Article
  4. Cobalt complexes in biology and medicine: enzymatic functions, pharmacological applications, and health challenges.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2026
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Laboratory evolution ofJournal of bacteriology · 2025
    Article
  12. Review
  13. Review
  14. Review
  15. Laboratory evolution ofbioRxiv : the preprint server for biology · 2024
    Article
  16. Article
  17. Emerging Roles of Vitamin BInternational journal of molecular sciences · 2024
    Review
  18. Article
  19. Article
  20. Review

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Robert H AllenDivision of Hematology, Department of Medicine, University of Colorado Health Sciences Center, Denver, CO 80262, USA. robert.allen@UCHSC.edu
Sally P Stabler
University of Colorado Anschutz Medical Campus · USUniversity of Colorado Health · US

Funding

PREVALENCE AND SPECTRUM OF B12 DEFICIENCY IN THE AGEDR01AG009834 · NIA · UNIVERSITY OF COLORADO DENVER · PI STABLER, SALLY P · 1991 to 2007
$1.7M
NIA NIH HHS AG-09834NIA NIH HHS R01 AG009834
6 · The paper itself

Abstract

backgroundCobalamin (vitamin B-12) and cobalamin analogues are present in human feces, but a complete identification has not been established, and the amounts present have not been determined.

objectivesWe aimed to develop a liquid chromatography-mass spectrometry method for cobalamin and cobalamin analogues and to identify and quantitiate the amounts present in human feces.

designFecal samples were obtained from 20 human subjects in good general health. The samples were analyzed for the presence and amounts of cobalamin and 12 cobalamin analogues that were synthesized with and without the incorporation of stable isotopes.

resultsCobalamin and 7 cobalamin analogues were identified and quantitated in human feces. The mean for the total amount present in 18 subjects whose daily intake was < or = 25 microg cobalamin from vitamin supplements was 1309 ng cobalamin equivalents/g wet wt of feces. Cobalamin (1.4%) and cobinamide (1.8%) (an incomplete corrinoid) represented a small portion of the total amount. Six cobalamin analogues that contain a base other than the 5,6-dimethylbenzimidizidole in cobalamin were present. The bases and their mean amounts (in %) are 2-methyladenine (60.6%), p-cresol (16.3%), adenine (12.5%), 2-(methylthio)adenine (15.5%), 5-hydroxybenzimidazole (1.8%), and phenol (0.1%). One subject ingested 1 mg cobalamin/d and another ingested 2 mg cobalamin/d, and they appeared to convert most of the cobalamin to cobinamide and the 4 analogues that contain the bases-2-methyladenine, p-cresol, adenine, and 2-(methylthio)adenine.

conclusionsCobalamin analogues are present in human feces and account for > 98% of the total of cobalamin plus cobalamin analogues. A major portion of large amounts of ingested cobalamin appears to be converted to cobalamin analogues.

Indexed as

DietAdultAgedAged, 80 and overChromatography, LiquidEubacteriumFecesFemaleHumansMaleMass SpectrometryMiddle AgedPropionibacteriumVitamin B 12Vitamin B ComplexVitamin B 12Vitamin B Complex

Identifiers

PMID18469256
PMCPMC2900183
OpenAlexW2118047561

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.